Literature DB >> 9849670

Surface expression and metabolic half-life of AMPA receptors in cultured rat cerebellar granule cells.

K Archibald1, M J Perry, E Molnár, J M Henley.   

Abstract

The surface expression and metabolic turnover time of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors are important factors in determining the involvement of these proteins in synaptic function. We used the membrane-impermeant chemical crosslinking reagent BS3 and subsequent immunoblot analysis to show that a large proportion of each of the AMPA receptor subunits GluR1-4 is surface expressed in cultured rat cerebellar granule cells. The apparent molecular mass of the individual subunits was 105 kDa and the surface expressed crosslinked complex was 530 kDa for each of the antibodies tested. These results are consistent with functional ionotropic glutamate receptors being pentameric subunit assemblies. We investigated the time course of AMPA receptor surface expression using the membrane-impermeant biotinylating agent NHS-SS-biotin. The half-life of surface expressed AMPA receptors was found to be 30 h. To estimate the mean degradation rate of AMPA receptors and total trichloracetic acid (TCA)-precipitable protein we used [35S]methionine/cysteine pulse-chase labelling. The half-life of AMPA receptors immunoprecipitated with anti-GluR1 antibody was approximately 48 h and the half-life of total TCA-precipitable protein from the same samples was 37 h.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849670     DOI: 10.1016/s0028-3908(98)00135-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  29 in total

1.  Regional localization and developmental profile of acetylcholinesterase-evoked increases in [(3)H]-5-fluororwillardiine binding to AMPA receptors in rat brain.

Authors:  S Olivera; D Rodriguez-Ithurralde; J M Henley
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 2.  Epigenetic mechanisms in memory and synaptic function.

Authors:  Faraz A Sultan; Jeremy J Day
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

Review 3.  Running to stand still: ionotropic receptor dynamics at central and peripheral synapses.

Authors:  Emile G Bruneau; Mohammed Akaaboune
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

4.  Modeling the role of lateral membrane diffusion in AMPA receptor trafficking along a spiny dendrite.

Authors:  B A Earnshaw; P C Bressloff
Journal:  J Comput Neurosci       Date:  2008-03-05       Impact factor: 1.621

5.  A protein cross-linking assay for measuring cell surface expression of glutamate receptor subunits in the rodent brain after in vivo treatments.

Authors:  Amy C Boudreau; Mike Milovanovic; Kelly L Conrad; Christopher Nelson; Carrie R Ferrario; Marina E Wolf
Journal:  Curr Protoc Neurosci       Date:  2012-04

Review 6.  Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction.

Authors:  Nilkantha Sen
Journal:  Neuromolecular Med       Date:  2014-04-29       Impact factor: 3.843

Review 7.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

8.  Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors.

Authors:  Marta Imbesi; Tolga Uz; Radmila Manev; Rajiv P Sharma; Hari Manev
Journal:  Neurosci Lett       Date:  2008-10-07       Impact factor: 3.046

9.  Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons.

Authors:  Can Gao; Marina E Wolf
Journal:  J Neurochem       Date:  2008-07-30       Impact factor: 5.372

10.  Spine-type-specific recruitment of newly synthesized AMPA receptors with learning.

Authors:  Naoki Matsuo; Leon Reijmers; Mark Mayford
Journal:  Science       Date:  2008-02-22       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.